SawkaAM, GhaiS, YoannidisT, RotsteinL, GullanePJ, GilbertRW, PasternakJD, BrownDH, EskanderA, de AlmeidaJR, IrishJC, HigginsK, EnepekidesDJ, MonteiroE, BanerjeeA, ShahM, GoodenE, ZahediA, KormanM, EzzatS, JonesJM, RacVE, TomlinsonG, StanimirovicA, GafniA, BaxterNN, GoldsteinDP. 2020. A prospective mixed-methods study of decision-making on surgery or active surveillance for low-risk papillary thyroid cancer. Thyroid, 30:999–1007.
2.
DaviesL, RomanBR, FukushimaM, ItoY, MiyauchiA. 2019. Patient experience of thyroid cancer active surveillance in Japan. JAMA Otolaryngol Head Neck Surg, 145:363–370.
3.
MiyauchiA. 2016. Clinical trials of active surveillance of papillary microcarcinoma of the thyroid. World J Surg, 40:516–522.
4.
ItoY, MiyauchiA, KudoT, OdaH, YamamotoM, SasaiH, MasuokaH, FukushimaM, HigashiyamaT, KiharaM, MiyaA. 2018. Trends in the implementation of active surveillance for low-risk papillary thyroid microcarcinomas at kuma hospital: gradual increase and heterogeneity in the acceptance of this new management option. Thyroid, 28:488–495.
